先看重点
267名在职成年人连续14天佩戴Fitbit Charge 2,夜间心率波动更大、步数节律更不规律者抑郁症状更重,但在全部样本中检出能力有限。80%的准确率仅出现在把抑郁者与无或极轻症状者作对比的子样本中,比真实筛查容易得多。
证据类型
横断面研究
解读依据
公开摘要
阅读重点
关联与混杂
研究在问什么
约半数抑郁症患者未被诊断和治疗,因此低成本、无打扰的筛查方式很有价值。作者检验了消费级可穿戴设备测得的行为和生理数据(数字生物标志物)能否识别在职人群的抑郁风险。
研究了谁,如何研究
横断面研究,共290名健康在职成年人,其中267人纳入分析。参与者连续14天佩戴Fitbit Charge 2,并在基线和2周后完成健康问卷,包括9项患者健康问卷(PHQ-9)。研究者根据步数、心率、能量消耗和睡眠数据提取活动、睡眠和昼夜节律相关的生物标志物。采用Spearman相关和多元回归分析关联,并校正社会人口特征、饮酒、吸烟、自评健康、主观睡眠和孤独感。监督式机器学习采用k折交叉验证,在留出折上评估,并使用不同的PHQ-9临界分数。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1抑郁症状越重,凌晨2点至4点以及4点至6点的夜间心率波动越大,这一关联较为稳健。
- 2症状越重,基于步数的工作日昼夜节律越不规律(日间稳定性和自相关),每日步数峰值也越少。
- 3尽管有这些可靠的关联,数字生物标志物在全部样本中检出抑郁的能力有限。
- 4在把抑郁者与无或极轻症状的健康者作对比的平衡子样本中,模型识别高抑郁风险者的准确率为80%,灵敏度为82%,特异度为78%。
局限与不确定性
- 1较高的准确率来自刻意对比的子样本,排除了症状处于中间程度的人,会高估在普通职场人群中的表现。
- 2样本较小且较同质:平均年龄33岁,79.0%为华人,89.1%具有大学学历,女性占63.7%。
- 3抑郁风险由自评问卷(PHQ-9)判定而非临床诊断,且横断面设计无法说明先后顺序。
- 4参与者只佩戴一种设备、持续14天,结果未必适用于其他设备或更长时间。本解读仅基于摘要。
对日常健康的启示
手环记录的睡眠、心率和步数规律不能当作抑郁检测,本研究在一般人群中的检出能力有限。研究发现的日常节律紊乱只是松散的信号。如果你连续数周情绪低落或担心自己的情绪,请咨询临床医生,而不要依赖设备数据。
如何联系自己的数据
本研究关注的正是夜间心率波动和每日步数节律的规律性这类数据。如果你想观察,请使用同一设备、保持相同的佩戴方式,看数周的趋势,而不是单个夜晚。
如何理解这类证据
同一时期的测量通常不能确定方向或因果;症状可能改变行为,不能只按行为导致症状解释。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Depression is a prevalent mental disorder that is undiagnosed and untreated in half of all cases. Wearable activity trackers collect fine-grained sensor data characterizing the behavior and physiology of users (ie, digital biomarkers), which could be used for timely, unobtrusive, and scalable depression screening.
Objective
The aim of this study was to examine the predictive ability of digital biomarkers, based on sensor data from consumer-grade wearables, to detect risk of depression in a working population.
Methods
This was a cross-sectional study of 290 healthy working adults. Participants wore Fitbit Charge 2 devices for 14 consecutive days and completed a health survey, including screening for depressive symptoms using the 9-item Patient Health Questionnaire (PHQ-9), at baseline and 2 weeks later. We extracted a range of known and novel digital biomarkers characterizing physical activity, sleep patterns, and circadian rhythms from wearables using steps, heart rate, energy expenditure, and sleep data. Associations between severity of depressive symptoms and digital biomarkers were examined with Spearman correlation and multiple regression analyses adjusted for potential confounders, including sociodemographic characteristics, alcohol consumption, smoking, self-rated health, subjective sleep characteristics, and loneliness. Supervised machine learning with statistically selected digital biomarkers was used to predict risk of depression (ie, symptom severity and screening status). We used varying cutoff scores from an acceptable PHQ-9 score range to define the depression group and different subsamples for classification, while the set of statistically selected digital biomarkers remained the same. For the performance evaluation, we used k-fold cross-validation and obtained accuracy measures from the holdout folds.
Results
A total of 267 participants were included in the analysis. The mean age of the participants was 33 (SD 8.6, range 21-64) years. Out of 267 participants, there was a mild female bias displayed (n=170, 63.7%). The majority of the participants were Chinese (n=211, 79.0%), single (n=163, 61.0%), and had a university degree (n=238, 89.1%). We found that a greater severity of depressive symptoms was robustly associated with greater variation of nighttime heart rate between 2 AM and 4 AM and between 4 AM and 6 AM; it was also associated with lower regularity of weekday circadian rhythms based on steps and estimated with nonparametric measures of interdaily stability and autocorrelation as well as fewer steps-based daily peaks. Despite several reliable associations, our evidence showed limited ability of digital biomarkers to detect depression in the whole sample of working adults. However, in balanced and contrasted subsamples comprised of depressed and healthy participants with no risk of depression (ie, no or minimal depressive symptoms), the model achieved an accuracy of 80%, a sensitivity of 82%, and a specificity of 78% in detecting subjects at high risk of depression.
Conclusions
Digital biomarkers that have been discovered and are based on behavioral and physiological data from consumer wearables could detect increased risk of depression and have the potential to assist in depression screening, yet current evidence shows limited predictive ability. Machine learning models combining these digital biomarkers could discriminate between individuals with a high risk of depression and individuals with no risk.
来源与署名
Digital Biomarkers for Depression Screening With Wearable Devices: Cross-sectional Study With Machine Learning Modeling.
Rykov Y, Thach TQ, Bojic I, Christopoulos G, Car J.
JMIR mHealth and uHealth · 2021-10-25
DOI: 10.2196/24872 ↗PubMed · 34694233 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
加速度计处理方法不同,身体活动与卒中、心肌梗死的关联曲线也不同
在英国生物银行中,基线无心血管疾病的90237名成年人随访至2022年12月,共发生1298例卒中和2031例心肌梗死;中高强度身体活动(MVPA)与这两种结局的关联曲线形状,取决于加速度计数据的处理方法。就卒中而言,只有机器学习法得到直线下降的风险;就心肌梗死而言,机器学习法和LFENMO法呈曲线下降,活动计数法呈直线下降。摘要没有给出风险比,只能说明不同方法的结论不一致,不能说明哪种方法更正确,而且这些只是观察性关联。
Preventive Medicine
智能手表数据能当“证人”吗:心率验证得最充分,其余证据参差
一项围绕数字取证展开的系统评价和荟萃分析,梳理了四大主流品牌智能手表的验证研究,发现心率是研究最多、也最准确的指标。步数、距离、能量消耗、活动分类和睡眠的验证不够一致,结果因品牌、方案和报告方式而异。摘要没有给出汇总数据,且多数研究是在健康人群中、于实验室内完成的,所以无法说明某一块手表对某个人在日常生活中的表现。
Forensic Science International
活动追踪器:每天多走约1800步,对其他健康指标影响较小
这项伞形综述汇总了39篇系统评价和荟萃分析,涉及163992名参与者;结果显示使用活动追踪器与身体活动增加相关(标准化均数差SMD为0.3–0.6),相当于每天多走约1800步、多步行40分钟,体重减轻约1公斤。对血压、胆固醇、糖化血红蛋白、生活质量和疼痛的影响通常很小,且多数不显著。摘要没有说明这些项目里追踪器还搭配了什么,也没有说明各评价之间重叠多少,因此不能把效果完全归功于设备本身。
The Lancet Digital Health
七款睡眠追踪设备:识别睡着很准,识别醒着和睡眠分期较差
在睡眠实验室里,34名健康的年轻成年人连续三晚佩戴七款消费级睡眠追踪设备中的若干款。与多导睡眠监测相比,所有设备识别睡眠都很准(灵敏度均不低于0.93),但识别清醒较差(特异度0.18–0.54),七款中有五款与研究用活动记录仪(特异度0.39)持平或更好;睡眠分期的估计结果不稳定。受试者是18至35岁的健康成年人,卧床时间固定为8小时,每款设备只在其中11至20人身上测试,因此对有睡眠问题的人几乎没有参考价值。
Sleep

